ARCHIVES

Revlimid Plus Steroid Effective In Clinical Trial

This article is from The Cancer Letter archive.

Vol. 30 No. 11 | November 30, 2007

Download PDF Visit The Full Archive

Related Articles

Symposium to Focus on New Approaches to Drug Resistance

May 11, 1990

Greenwald Lists Items Missing Because Not Enough Money Available

November 25, 1988

ACS Issues Challenge To cut Death Rate From Cancer In Half

November 22, 1996

NCAB Approves New Grant Award Honoring Howard Temin

March 8, 1996

Genomic Health Presents Meta-Analyses of Oncotype DX

January 28, 2011

ACS Asks $1.5 Billion for NCI; Waxman Considers Requiring NIH To Send Budget Directly To Congress

March 4, 1983